Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse ...

SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today ...

Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced ...

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson's rashes, swelling, fevers and severe pain for six years. She saved her life by begging for one more test in an emergency room that was ...

Researchers used artificial intelligence to obtain a more objective understanding of cell growth and division without preconceived assumptions. Using a deep-learning neural network, they were able to ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

Patricia Brennan speaks of the mission for science technology at the Chan Zuckerberg Initiative (CZI) by trying to reach the same level of conviction that marked President John F. Kennedy’s legendary ...

Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients Drug discovery research collaboration may initiate up to seven oncology ...

It's easy to focus on the nuances that get lost in translation, but what about the insights that are found? This hour, TED speakers reveal what we gain by adapting and translating information. Guests ...

image: Researchers at The University of Tokyo Institute of Industrial Science use artificial intelligence to predict the size of cells over time without the need for simplifying assumptions, which may ...